UPDATE 1-Merck up as Zetia trial less damaging than feared
Zetia trial results less damaging to Merck than expected * Merck shares rise 2.7 pct; Abbott up 1.3 pct * Trial results presented at AHA meeting in Orlando (Updates with details, additional analyst comment) By Toni Clarke...



